WO1998046204A1 - Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique - Google Patents
Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique Download PDFInfo
- Publication number
- WO1998046204A1 WO1998046204A1 PCT/FR1998/000538 FR9800538W WO9846204A1 WO 1998046204 A1 WO1998046204 A1 WO 1998046204A1 FR 9800538 W FR9800538 W FR 9800538W WO 9846204 A1 WO9846204 A1 WO 9846204A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- seeds
- irvingia gabonensis
- fraction
- cosmetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the chemical composition of the Irvingia seed is, according to the literature, the following (according to OL OKE, Nutrition reports international, 1978, vol. 17 n ° 3, 293-297 and ONYECHI EN, Food chemistry, 1995, 53 , 2, 173-175): protein: 8.8 - 10.6% fat: 55 - 62.2% carbohydrates: 19.2 - 19.6% fiber: 8.2% Seed oil 'Irvingia gabonensis, which is solid at room temperature contains 55-59% myristic acid and 35-36.3% lauric acid.
- Irvingia fat in the preparation of margarine, cooking oil, soaps and pharmaceuticals was discussed. This fat has in particular been studied for the preparation of suppositories or as a lubricant for granules or tablets.
- the inventors of the present invention have unexpectedly and surprisingly found that, apart from their known thickening properties, the extracts of Irvingia gabonensis, in particular the fractions polysaccharides of Irvingia gabonensis, could be directly used in cosmetic and pharmaceutical products for external application and presented immediate properties more varied and quantitatively more important than the polysaccharides already used currently in cosmetic or pharmaceutical products, namely hydrating, film-forming properties , softening and restructuring.
- the lipid or fat fraction can also be used in such products and exhibits particular properties, such as good chemical stability and low coloring.
- the general object of the present invention consists in the use of at least one extract of Irvingia gabonensis as active agent (s) for the preparation of a cosmetic and / or pharmaceutical product. topical use for the skin and / or the integuments, this or these extract (s) being preferably obtained from the seeds of the Irvingia gabonensis tree.
- the extract used consists of the polysaccharide fraction of the seeds, where appropriate in the form of crude polysaccharide extract.
- the extract used consists of a part of the polysaccharide fraction of the seeds, if necessary in the form of a purified polysaccharide.
- the polysaccharide fraction or the polysaccharide is preferably extracted from the seeds of the Irvingia gabonensis tree by water or aqueous solutions at neutral, alkaline or acid pH.
- the extract used can consist of the lipid or fat fraction of Irvingia gabonensis seeds, alone or combined with the fraction or part of the polysaccharide fraction of said seeds.
- Example 1 By way of nonlimiting examples, various methods of obtaining possible extracts of seeds of Irvingia gabonensis, in particular fat and polysaccharides, used in the context of the present invention will be described below.
- Example 1
- the total crude oil yield of this process is 71.8%.
- the crude oil of Irvingia gabonensis can be refined and deodorized by the usual techniques known to those skilled in the art to give a solid white oil which is perfectly odorless.
- the residue insoluble in hexane is a beige-colored powder representing 260 grams or 27% by weight relative to the initial whole seed.
- the viscous suspension is centrifuged for 15 minutes at 5000 g.
- the supernatant is filtered through a nylon cloth in order to retain a weak lipid layer.
- the upper phase (layer of fat) is eliminated, the aqueous phase is filtered through a cloth and 1.55 liters of supernatant are collected. The supernatant is again centrifuged and the polysaccharides are then precipitated in two volumes of absolute ethanol, then treated as in Example 2.
- the process for preparing and manufacturing the abovementioned emulsion essentially consists, after mixing their constituents, in heating the fractions A and B separately to around 70 ° C., in mixing these two fractions and in homogenizing it, and, finally, stir the resulting mixture until cooling to room temperature.
- Example 2
- a cosmetic product in accordance with the invention in the form of moisturizing milk for the body (O / W) may, for example, have a weight composition, consisting of the following fractions A and B, as indicated below.
- the process for the preparation and manufacture of the above-mentioned hydrating milk essentially consists in mixing the constituents of the fatty fraction A and heating them to 70 ° C., in adding the Carbomer to them, in mixing the other constituents of the aqueous fraction B and in heat to 70 ° C, pour fraction B into fraction A and stir the mixture until cooling to room temperature and, finally, homogenize the resulting emulsion.
- the process for preparing and manufacturing the above-mentioned cream essentially consists in mixing and heating the fatty fraction A to 90 ° C., in preparing the aqueous fraction B by stirring at 75 ° C., in pouring the fraction A into the fraction B with turbine stirring, add fraction C to it, stop the turbine stirring at around 50 ° C and carry out planetary stirring until cooling to room temperature.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98914937A EP0977550B1 (fr) | 1997-04-14 | 1998-03-17 | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique |
AT98914937T ATE303127T1 (de) | 1997-04-14 | 1998-03-17 | Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten |
US09/402,834 US6216707B1 (en) | 1997-04-14 | 1998-03-17 | Use of at least an Irvingia gabonensis extract in a cosmetic and/or pharmaceutical product |
DE69831404T DE69831404T2 (de) | 1997-04-14 | 1998-03-17 | Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten |
AU69246/98A AU6924698A (en) | 1997-04-14 | 1998-03-17 | Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product |
KR1019997009422A KR100564824B1 (ko) | 1997-04-14 | 1998-03-17 | 적어도 하나의 야생 망고 나무 추출물이 화장품 및 약품으로 사용되는 용도 |
CA002288284A CA2288284A1 (fr) | 1997-04-14 | 1998-03-17 | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique |
JP54354198A JP2001518909A (ja) | 1997-04-14 | 1998-03-17 | 化粧品および/または医薬品における、少なくとも1種類のIrvingia gabonensis抽出物の使用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR97/04732 | 1997-04-14 | ||
FR9704732A FR2761885B1 (fr) | 1997-04-14 | 1997-04-14 | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998046204A1 true WO1998046204A1 (fr) | 1998-10-22 |
Family
ID=9506021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1998/000538 WO1998046204A1 (fr) | 1997-04-14 | 1998-03-17 | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique |
Country Status (11)
Country | Link |
---|---|
US (1) | US6216707B1 (fr) |
EP (1) | EP0977550B1 (fr) |
JP (1) | JP2001518909A (fr) |
KR (1) | KR100564824B1 (fr) |
AT (1) | ATE303127T1 (fr) |
AU (1) | AU6924698A (fr) |
CA (1) | CA2288284A1 (fr) |
DE (1) | DE69831404T2 (fr) |
ES (1) | ES2248895T3 (fr) |
FR (1) | FR2761885B1 (fr) |
WO (1) | WO1998046204A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814063A1 (fr) * | 2000-09-15 | 2002-03-22 | Clarins Lab | Composition cosmetique pour le soin des levres |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060263450A1 (en) * | 2005-05-17 | 2006-11-23 | Julius Oben | Method and composition for reducing body weight and improving control of body lipids |
US7726320B2 (en) | 2006-10-18 | 2010-06-01 | R. J. Reynolds Tobacco Company | Tobacco-containing smoking article |
US20100098792A1 (en) * | 2008-10-17 | 2010-04-22 | Gateway Health Alliances, Inc. | Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglycerides levels and increase adiponectin levels |
US20100098793A1 (en) * | 2008-10-17 | 2010-04-22 | Gateway Health Alliances, Inc. | Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing adiponectin levels |
US20120125354A1 (en) | 2010-11-18 | 2012-05-24 | R.J. Reynolds Tobacco Company | Fire-Cured Tobacco Extract and Tobacco Products Made Therefrom |
CN104284605B (zh) | 2012-03-19 | 2018-02-23 | R.J.雷诺兹烟草公司 | 用于处理提取的烟草浆的方法和由此制备的烟草产品 |
US11019850B2 (en) | 2018-02-26 | 2021-06-01 | Rai Strategic Holdings, Inc. | Heat conducting substrate for electrically heated aerosol delivery device |
US11753750B2 (en) | 2018-11-20 | 2023-09-12 | R.J. Reynolds Tobacco Company | Conductive aerosol generating composite substrate for aerosol source member |
US11324249B2 (en) | 2019-03-06 | 2022-05-10 | R.J. Reynolds Tobacco Company | Aerosol delivery device with nanocellulose substrate |
CA3147881A1 (fr) | 2019-07-18 | 2021-01-21 | R.J. Reynolds Tobacco Company | Absorbeurs d'energie thermique destines a la production de produits permettant de chauffer du tabac |
US20210195938A1 (en) | 2019-12-27 | 2021-07-01 | Nicoventures Trading Limited | Substrate with multiple aerosol forming materials for aerosol delivery device |
US20210321655A1 (en) | 2020-04-16 | 2021-10-21 | R.J. Reynolds Tobacco Company | Aerosol delivery device including a segregated substrate |
US11771132B2 (en) | 2020-08-27 | 2023-10-03 | Rai Strategic Holdings, Inc. | Atomization nozzle for aerosol delivery device |
US11771136B2 (en) | 2020-09-28 | 2023-10-03 | Rai Strategic Holdings, Inc. | Aerosol delivery device |
CA3224138A1 (fr) | 2021-06-30 | 2023-01-05 | Nicoventures Trading Limited | Substrat avec de multiples substances de formation d'aerosol pour dispositif de distribution d'aerosol |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964500A (en) * | 1973-12-26 | 1976-06-22 | Lever Brothers Company | Lusterizing shampoo containing a polysiloxane and a hair-bodying agent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4405127A1 (de) * | 1994-02-18 | 1995-08-31 | Henkel Kgaa | Haarbehandlungsmittel |
FR2723311B1 (fr) * | 1994-08-02 | 1996-10-25 | Oreal | Procede de traitement des fibres keratiniques humaines a l'aide d'amides a chaine grasse et de vapeur d'eau |
TW527191B (en) * | 1997-07-09 | 2003-04-11 | Kao Corp | Hair treatment composition |
-
1997
- 1997-04-14 FR FR9704732A patent/FR2761885B1/fr not_active Expired - Lifetime
-
1998
- 1998-03-17 AT AT98914937T patent/ATE303127T1/de not_active IP Right Cessation
- 1998-03-17 EP EP98914937A patent/EP0977550B1/fr not_active Expired - Lifetime
- 1998-03-17 DE DE69831404T patent/DE69831404T2/de not_active Expired - Lifetime
- 1998-03-17 KR KR1019997009422A patent/KR100564824B1/ko not_active IP Right Cessation
- 1998-03-17 CA CA002288284A patent/CA2288284A1/fr not_active Abandoned
- 1998-03-17 ES ES98914937T patent/ES2248895T3/es not_active Expired - Lifetime
- 1998-03-17 US US09/402,834 patent/US6216707B1/en not_active Expired - Lifetime
- 1998-03-17 JP JP54354198A patent/JP2001518909A/ja active Pending
- 1998-03-17 AU AU69246/98A patent/AU6924698A/en not_active Abandoned
- 1998-03-17 WO PCT/FR1998/000538 patent/WO1998046204A1/fr active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964500A (en) * | 1973-12-26 | 1976-06-22 | Lever Brothers Company | Lusterizing shampoo containing a polysiloxane and a hair-bodying agent |
Non-Patent Citations (3)
Title |
---|
CHEMICAL ABSTRACTS, vol. 112, no. 26, 25 June 1990, Columbus, Ohio, US; abstract no. 240425, XP002052300 * |
E. N. ONYEIKE ET AL.: "Effect of heat-treatment and defatting on the proximate composition of some Nigerian local soup thickeners.", FOOD CHEMISTRY, vol. 53, no. 2, 1995, GB, pages 173 - 175, XP002052760 * |
J. O. ONYECHI ET AL.: "the tabletting properties of dika fat lubricant", DRUG. DEV. IND. PHARM., vol. 16, no. 7, 1990, pages 1203 - 1216 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814063A1 (fr) * | 2000-09-15 | 2002-03-22 | Clarins Lab | Composition cosmetique pour le soin des levres |
Also Published As
Publication number | Publication date |
---|---|
EP0977550A1 (fr) | 2000-02-09 |
DE69831404T2 (de) | 2006-07-27 |
JP2001518909A (ja) | 2001-10-16 |
EP0977550B1 (fr) | 2005-08-31 |
CA2288284A1 (fr) | 1998-10-22 |
KR100564824B1 (ko) | 2006-03-30 |
AU6924698A (en) | 1998-11-11 |
ATE303127T1 (de) | 2005-09-15 |
DE69831404D1 (de) | 2005-10-06 |
FR2761885A1 (fr) | 1998-10-16 |
KR20010006337A (ko) | 2001-01-26 |
ES2248895T3 (es) | 2006-03-16 |
FR2761885B1 (fr) | 1999-06-04 |
US6216707B1 (en) | 2001-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0977550B1 (fr) | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique | |
EP0504236B1 (fr) | Utilisation d'extraits d'algues pour la preparation de compositions pharmaceutiques, cosmetiques, alimentaires ou a usage agricole | |
FR3076460A1 (fr) | Utilisation cosmetique d'un extrait proteique des graines de moringa oleifera | |
EP0973494B1 (fr) | Utilisation d'un extrait du genre adansonia | |
JP3448669B2 (ja) | ラノリン脂肪酸エステル類、化粧料及び外用薬 | |
JP4229236B2 (ja) | 加水分解されたホホバプロテインを調製する方法および加水分解されたホホバプロテインを含む調合物 | |
EP0742007A1 (fr) | Utilisation d'extraits de graines de cassia et/ou de trigonelle enrichis en galactomannanes et produit cosmétique ou pharmaceutique, notamment dermatologique, contenant de tels extraits | |
JP3118020B2 (ja) | 化粧料 | |
JP5464778B2 (ja) | 頭髪化粧料 | |
JPH0413608A (ja) | ステロールエステル化物 | |
FR2477413A1 (fr) | Compositions cosmetiques liquides et claires pour les soins de la peau | |
FR2487674A1 (fr) | Produit cosmetique presentant des effets de regeneration sur la peau et les muscles et procede pour la preparation de ce produit cosmetique | |
JPH0520411B2 (fr) | ||
JP2002284632A (ja) | 酒粕を有効成分とするスーパーオキシドアニオン消去物質 | |
JPH1036282A (ja) | ムコ多糖類切断抑制剤 | |
FR2839308A1 (fr) | Derive de diol et composition le contenant | |
JP7479038B2 (ja) | ペプチジルアルギニンデイミナーゼ1発現促進剤 | |
FR2761888A1 (fr) | Composition cosmetique ou pharmaceutique contenant un extrait d'andiroba | |
WO1997034579A1 (fr) | Extrait de graines d'amarante et composition dermo-cosmetique le comprenant | |
FR2775686A1 (fr) | Exploitation industrielle et commerciale des lipides cuticulaires de la baie de raisin en pharmacologie et cosmetologie | |
FR2780277A1 (fr) | Utilisation d'au moins un extrait lipidique de noyaux de fruits du mirabellier | |
JPH0333684B2 (fr) | ||
JP2003137766A (ja) | 皮膚外用コラーゲン産生促進剤及び皮膚外用ヒアルロン酸産生促進剤 | |
JP2002020256A (ja) | 皮膚外用剤 | |
FR2772616A1 (fr) | Composition depigmentante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 1998 543541 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2288284 Country of ref document: CA Kind code of ref document: A Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998914937 Country of ref document: EP Ref document number: 09402834 Country of ref document: US Ref document number: 1019997009422 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 69246/98 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1998914937 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997009422 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998914937 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019997009422 Country of ref document: KR |